Skip to main content

Table 4 Demographic characteristics, laboratory results, and outcomes of the patient’s treatment according to the first two waves

From: COVID-19 in Kidney Transplant Recipients: A Multicenter Experience from the First Two Waves of Pandemic

 

All patients (n = 475)

First wave (n = 138)

Second wave (n = 337)

p-value

Age

47 (37–56)

46 (36–55)

47 (37–56)

0.456

CRP levels

20 (5–57)

38 (13–78)

14 (4–46)

 < 0.0001

Lymphocyte

1000 (670–1595)

900 (599–1370)

1100 (700–1700)

0.012

LDH levels

238 (189–317)

244 (184–313)

235 (189–319)

0.92

Ferritin levels

354 (130–768)

313 (169–680)

377 (112–806)

0.87

Acute kidney injury

168 (35.4)

61 (44.2)

107 (31.8)

0.009

ARDS

80 (16.8)

26 (18.8)

54 (16)

0.456

Cytokine storm

56 (11.8)

22 (15.9)

34 (10.1)

0.072

Outpatient clinic

211 (44.4)

23 (16.7)

188 (55.8)

 < 0.0001

Hospitalization

195 (41.1)

95 (68.8)

100 (29.7)

 < 0.0001

ICU admission

69 (14.5)

20 (14.5)

49 (14.5)

0.989

Death

47 (9.9)

14 (10.1)

33 (9.8)

0.907

  1. Abbreviations: ARDS Acute respiratory distress syndrome, ICU Intensive care unit
  2. P-values compared first and second wave obtained from the Chi-Square test or Mann–Whitney U test
  3. Data were presented as n (%) or median [Interquartile range 25–75]
  4. Bold indicates statistically significant (p < 0.05)